Author

Leila Eshraghi

Garvan Institute of Medical Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Antonia L. CadelliD· 1 shared Carla L. AlvesiD· 1 shared Catherine Elizabeth CaldoniD· 1 shared Celine E Wiharja· 1 shared Christine S Lee· 1 shared Daniel A. ReediD· 1 shared David R. CroucheriD· 1 shared Elgene LimiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Antonia L. CadellORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

JNK pathway suppression drives resistance to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer

Sarah Alexandrou, Christine S Lee, Kristine J. Fernandez, Celine E Wiharja, Leila Eshraghi, John Reeves, Daniel A. Reed, Neil Portman, Zoe Phan, Heloisa Helena Milioli, Iva Nikolić, Antonia L. Cadell, David R. Croucher, Kaylene J. Simpson, Elgene Lim, , Catherine Elizabeth Caldon

This study identifies JNK pathway suppression as a driver of resistance to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer, with implications for patient stratification.

bioRxiv · Jan 8, 2025 · PreprintCancer Biology